Form 4: Rothblatt Reports Stock Transactions

Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, reported transactions involving common stock on May 26, 2026.

Summary

• Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, filed a Form 4 detailing changes in beneficial ownership of company stock.
• The transactions occurred on May 26, 2026.
• Rothblatt reported the disposition of 9,009 shares of common stock via a bona fide gift, resulting in 249,108 shares held indirectly by a trust.
• An additional 2,060 shares were disposed of via a bona fide gift, with 8,902 shares remaining indirectly held by a trust.
• Other holdings include 166 shares held indirectly by a spouse, 324,443 shares held indirectly by a trust, and 45,596 shares held indirectly by another trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine stock dispositions via gifts by an executive and does not contain financial performance data or strategic updates.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders and do not inherently signal strategic shifts, but they provide transparency into insider activity.

Related Party Transactions

• Dispositions of stock were made as bona fide gifts.
• Shares are held in various trusts, some with the reporting person or their spouse as trustee or beneficiary, and some where investment power is shared.

Stakeholder Impact

• Shareholders are informed of changes in beneficial ownership by a key executive.
• The filing provides transparency regarding the distribution of company stock.

Key Dates

Keywords

Form 4, SEC Filing, Beneficial Ownership, Stock Transaction, United Therapeutics Corp, Martine Rothblatt, Insider Trading, Gift of Stock